Literature DB >> 22936693

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

Brian D Juran1, Gideon M Hirschfield, Pietro Invernizzi, Elizabeth J Atkinson, Yafang Li, Gang Xie, Roman Kosoy, Michael Ransom, Ye Sun, Ilaria Bianchi, Erik M Schlicht, Ana Lleo, Catalina Coltescu, Francesca Bernuzzi, Mauro Podda, Craig Lammert, Russell Shigeta, Landon L Chan, Tobias Balschun, Maurizio Marconi, Daniele Cusi, E Jenny Heathcote, Andrew L Mason, Robert P Myers, Piotr Milkiewicz, Joseph A Odin, Velimir A Luketic, Bruce R Bacon, Henry C Bodenheimer, Valentina Liakina, Catherine Vincent, Cynthia Levy, Andre Franke, Peter K Gregersen, Fabrizio Bossa, M Eric Gershwin, Mariza deAndrade, Christopher I Amos, Konstantinos N Lazaridis, Michael F Seldin, Katherine A Siminovitch.   

Abstract

To further characterize the genetic basis of primary biliary cirrhosis (PBC), we genotyped 2426 PBC patients and 5731 unaffected controls from three independent cohorts using a single nucleotide polymorphism (SNP) array (Immunochip) enriched for autoimmune disease risk loci. Meta-analysis of the genotype data sets identified a novel disease-associated locus near the TNFSF11 gene at 13q14, provided evidence for association at six additional immune-related loci not previously implicated in PBC and confirmed associations at 19 of 22 established risk loci. Results of conditional analyses also provided evidence for multiple independent association signals at four risk loci, with haplotype analyses suggesting independent SNP effects at the 2q32 and 16p13 loci, but complex haplotype driven effects at the 3q25 and 6p21 loci. By imputing classical HLA alleles from this data set, four class II alleles independently contributing to the association signal from this region were identified. Imputation of genotypes at the non-HLA loci also provided additional associations, but none with stronger effects than the genotyped variants. An epistatic interaction between the IL12RB2 risk locus at 1p31and the IRF5 risk locus at 7q32 was also identified and suggests a complementary effect of these loci in predisposing to disease. These data expand the repertoire of genes with potential roles in PBC pathogenesis that need to be explored by follow-up biological studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22936693      PMCID: PMC3490520          DOI: 10.1093/hmg/dds359

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  51 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies.

Authors:  Daniel Falush; Matthew Stephens; Jonathan K Pritchard
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

3.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

4.  Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells.

Authors:  Karin Loser; Annette Mehling; Stefanie Loeser; Jenny Apelt; Annegret Kuhn; Stephan Grabbe; Thomas Schwarz; Josef M Penninger; Stefan Beissert
Journal:  Nat Med       Date:  2006-12-03       Impact factor: 53.440

5.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.

Authors:  Akinori Takaoka; Hideyuki Yanai; Seiji Kondo; Gordon Duncan; Hideo Negishi; Tatsuaki Mizutani; Shin-Ichi Kano; Kenya Honda; Yusuke Ohba; Tak W Mak; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-01-23       Impact factor: 49.962

Review 6.  Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.

Authors:  Margherita T Cantorna; Brett D Mahon
Journal:  Exp Biol Med (Maywood)       Date:  2004-12

7.  Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.

Authors:  G M Hirschfield; G Xie; E Lu; Y Sun; B D Juran; V Chellappa; C Coltescu; A L Mason; P Milkiewicz; R P Myers; J A Odin; V A Luketic; B Bacon; H Bodenheimer; V Liakina; C Vincent; C Levy; S Pillai; K N Lazaridis; C I Amos; K A Siminovitch
Journal:  Genes Immun       Date:  2012-01-19       Impact factor: 2.676

8.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.

Authors:  Y Y Kong; H Yoshida; I Sarosi; H L Tan; E Timms; C Capparelli; S Morony; A J Oliveira-dos-Santos; G Van; A Itie; W Khoo; A Wakeham; C R Dunstan; D L Lacey; T W Mak; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

9.  Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

Authors:  Ruth Y Lan; Chunmei Cheng; Zhe-Xiong Lian; Koichi Tsuneyama; Guo-Xiang Yang; Yuki Moritoki; Ya-Hui Chuang; Takafumi Nakamura; Shigeru Saito; Shinji Shimoda; Atsushi Tanaka; Christopher L Bowlus; Yasuo Takano; Aftab A Ansari; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

Review 10.  Interpreting serological tests in diagnosing autoimmune liver diseases.

Authors:  Pietro Invernizzi; Ana Lleo; Mauro Podda
Journal:  Semin Liver Dis       Date:  2007-05       Impact factor: 6.115

View more
  62 in total

Review 1.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

2.  Association between STAT4 polymorphisms and risk of primary biliary cholangitis: a meta-analysis.

Authors:  Li Zhang; Chunming Gao; Chuanmiao Liu; Jiasheng Chen; Kuihua Xu
Journal:  Genes Genomics       Date:  2018-06-28       Impact factor: 1.839

3.  An ImmunoChip study of multiple sclerosis risk in African Americans.

Authors:  Noriko Isobe; Lohith Madireddy; Pouya Khankhanian; Takuya Matsushita; Stacy J Caillier; Jayaji M Moré; Pierre-Antoine Gourraud; Jacob L McCauley; Ashley H Beecham; Laura Piccio; Joseph Herbert; Omar Khan; Jeffrey Cohen; Lael Stone; Adam Santaniello; Bruce A C Cree; Suna Onengut-Gumuscu; Stephen S Rich; Stephen L Hauser; Stephen Sawcer; Jorge R Oksenberg
Journal:  Brain       Date:  2015-03-28       Impact factor: 13.501

Review 4.  Genetics in PBC: what do the "risk genes" teach us?

Authors:  Gideon M Hirschfield; Katherine A Siminovitch
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 5.  Statistical power and significance testing in large-scale genetic studies.

Authors:  Pak C Sham; Shaun M Purcell
Journal:  Nat Rev Genet       Date:  2014-05       Impact factor: 53.242

6.  Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis.

Authors:  Craig Lammert; Brian D Juran; Erik Schlicht; Xiao Xie; Elizabeth J Atkinson; Mariza de Andrade; Konstantinos N Lazaridis
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-16       Impact factor: 11.382

Review 7.  Primary biliary cholangitis: a comprehensive overview.

Authors:  Ana Lleo; Simona Marzorati; Juan-Manuel Anaya; M Eric Gershwin
Journal:  Hepatol Int       Date:  2017-11-21       Impact factor: 6.047

8.  The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Authors:  Gideon M Hirschfield; Jessica K Dyson; Graeme J M Alexander; Michael H Chapman; Jane Collier; Stefan Hübscher; Imran Patanwala; Stephen P Pereira; Collette Thain; Douglas Thorburn; Dina Tiniakos; Martine Walmsley; George Webster; David E J Jones
Journal:  Gut       Date:  2018-03-28       Impact factor: 23.059

Review 9.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

Review 10.  Mechanisms of tissue injury in autoimmune liver diseases.

Authors:  Evaggelia Liaskou; Gideon M Hirschfield; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2014-08-01       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.